Nevertheless, more research is needed on a larger sample of patients to clarify whether EDN, PAF, and VEGF may be prognostic tools prior to AD exacerbations, biomarkers of this disease or new effective targeted therapies. Here, VEGFA is linked to Alzheimer disease.